VascuLife® EnGS-Mv Microvascular Endothelial Kit


In stock

SKU: LL-0004 Category: Tag: GTIN: 1021000000000


Product Description

VascuLife® EnGS-Mv Medium (containing Endothelial Cell Growth Supplement) is optimized for the culture of Human Microvascular Endothelial Cells.

  • VascuLife® culture medium supports the rapid proliferation of these cells in a 5% serum environment.

VascuLife® Basal Medium contains no antimicrobials and no phenol red.

VascuLife® EnGS-Mv is offered in a kit format, composed of basal medium (in a light-protected 500 mL bottle). This kit allows you to prepare fresh complete medium in your laboratory, extending shelf life and enhancing performance.

The LifeFactors Kit with associated supplements and growth factors.includes:

VascuLife Microvascular Endothelial Culture Medium

VascuLife® EnGS-Mv Medium grows Human Microvascular Endothelial Cells, without the addition of human VEGF, at rates that meet or exceed other commercially available serum-containing media while maintaining excellent cell morphology. In comparisons with other commercially-available media, VascuLife® shows superior proliferation at different seeding densities.

Human Microvascular Endothelial Cells Medium Testing

Shown above: Human Dermal Microvascular Endothelial Cells, passage 2, 4 days after inoculation with 5,000 cells/cm2 (100X).

Shown below: Human Dermal Microvascular Endothelial Cells inoculated at low seeding density in 24-well plates. Higher fluorescence represents a greater number of cells per well, and therefore, better proliferation.

VascuLife Microvascular Cell Culture Medium Comparison

Extensive Testing for Guaranteed Consistency and Reproducible Results

VascuLife® EnGS-Mv  culture medium is quality tested for:

  • Sterility:  Negative for bacteria and fungal growth
  • pH:  7.8 +/- 0.3
  • Osmolality:  270 +/- 10 mOsm
  • Endotoxin:  < 0.5 EU/mL

Our ISO-style quality assurance ensures lot-to-lot consistency in every production run.

Spec Sheets

Protocols & Instructions


No products in the cart.